GRB2 and Alzheimer disease: Using network pharmacology analysis, we identified 311 protein targets common to both GS-Rd and AD and certain targets of GS-Rd (e.g., SRC, MAPK1, JAK2, STAT3, and GRB2), which are known to be important in AD biology (Li et al., 2019; Reichenbach et al., 2019; Wang et al., 2019; Yang et al., 2020; Roberts et al., 2021).